Audhya Paul K.
Insider CIK 1860131 · KALV Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 40,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 93,750 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 100,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 68,750 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 25,800 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer | 2026-06-11 | 2026-06-11 | 150,260 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-26 | 2026-05-27 | 2,239 | $26.78 | $60.0K | 150,260 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-22 | 2026-05-27 | 5,000 | — | $0 | 40,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-22 | 2026-05-26 | 2,685 | $26.78 | $71.9K | 147,499 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-22 | 2026-05-27 | 5,000 | — | $0 | 152,499 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-21 | 2026-05-26 | 6,250 | — | $0 | 68,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-21 | 2026-05-26 | 6,250 | — | $0 | 150,184 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-18 | 2026-05-19 | 1,032 | $26.76 | $27.6K | 143,934 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-17 | 2026-05-19 | 2,419 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-17 | 2026-05-19 | 2,419 | — | $0 | 144,966 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-04-17 | 2026-04-20 | 2,686 | $20.22 | $54.3K | 142,547 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-04-16 | 2026-04-20 | 6,250 | — | $0 | 93,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-04-16 | 2026-04-20 | 6,250 | — | $0 | 145,233 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-23 | 2026-02-24 | 5,354 | $15.57 | $83.4K | 138,983 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-22 | 2026-02-24 | 5,000 | — | $0 | 45,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-22 | 2026-02-24 | 5,000 | — | $0 | 144,337 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-21 | 2026-02-24 | 6,250 | — | $0 | 75,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-21 | 2026-02-24 | 6,250 | — | $0 | 139,337 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-18 | 2026-02-19 | 1,163 | $15.00 | $17.4K | 133,087 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-17 | 2026-02-19 | 2,419 | — | $0 | 2,419 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-17 | 2026-02-19 | 2,419 | — | $0 | 134,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2026-01-16 | 2026-01-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-24 | 2025-11-26 | 5,296 | $13.45 | $71.2K | 131,831 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-22 | 2025-11-26 | 5,000 | — | $0 | 50,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-22 | 2025-11-26 | 5,000 | — | $0 | 137,127 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-21 | 2025-11-26 | 6,250 | — | $0 | 81,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-21 | 2025-11-26 | 6,250 | — | $0 | 132,127 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-18 | 2025-11-19 | 3,075 | $14.48 | $44.5K | 125,877 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-17 | 2025-11-19 | 4,028 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-17 | 2025-11-19 | 2,419 | — | $0 | 4,838 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-17 | 2025-11-19 | 6,447 | — | $0 | 128,952 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-25 | 2025-08-26 | 2,336 | $13.42 | $31.3K | 122,505 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-22 | 2025-08-26 | 5,000 | — | $0 | 55,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-22 | 2025-08-25 | 2,942 | $13.22 | $38.9K | 119,841 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-22 | 2025-08-26 | 5,000 | — | $0 | 124,841 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-21 | 2025-08-25 | 6,250 | — | $0 | 87,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-21 | 2025-08-25 | 6,250 | — | $0 | 122,783 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-18 | 2025-08-19 | 2,939 | $13.19 | $38.8K | 116,533 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-17 | 2025-08-19 | 4,028 | — | $0 | 4,028 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-17 | 2025-08-19 | 2,418 | — | $0 | 7,257 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-17 | 2025-08-19 | 6,446 | — | $0 | 119,472 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-05-23 | 2025-05-27 | 2,146 | $11.31 | $24.3K | 113,026 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-22 | 2025-05-27 | 5,000 | — | $0 | 60,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-05-22 | 2025-05-23 | 2,689 | $11.88 | $31.9K | 110,172 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-05-22 | 2025-05-27 | 5,000 | — | $0 | 115,172 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-21 | 2025-05-23 | 6,250 | — | $0 | 93,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-05-21 | 2025-05-23 | 6,250 | — | $0 | 112,861 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-05-19 | 2025-05-20 | 2,776 | $11.84 | $32.9K | 106,611 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-17 | 2025-05-20 | 2,419 | — | $0 | 9,675 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-17 | 2025-05-20 | 4,028 | — | $0 | 8,056 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-05-17 | 2025-05-20 | 6,447 | — | $0 | 109,387 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-02-24 | 2025-02-25 | 2,394 | $10.02 | $24.0K | 102,940 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-02-22 | 2025-02-25 | 5,000 | — | $0 | 65,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-02-22 | 2025-02-25 | 5,000 | — | $0 | 105,334 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-02-21 | 2025-02-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-02-18 | 2025-02-19 | 3,125 | $9.82 | $30.7K | 100,334 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-02-17 | 2025-02-19 | 4,028 | — | $0 | 12,084 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-02-17 | 2025-02-19 | 2,419 | — | $0 | 12,094 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-02-17 | 2025-02-19 | 6,447 | — | $0 | 103,459 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-11-26 | 2024-11-27 | 2,187 | $9.87 | $21.6K | 97,012 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-22 | 2024-11-27 | 5,000 | — | $0 | 70,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-11-22 | 2024-11-27 | 5,000 | — | $0 | 99,199 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-11-18 | 2024-11-19 | 8,077 | $9.26 | $74.8K | 94,199 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 12,084 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 2,419 | — | $0 | 14,513 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 4,028 | — | $0 | 16,112 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-11-17 | 2024-11-19 | 18,531 | — | $0 | 102,276 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-08-23 | 2024-08-26 | 2,135 | $12.40 | $26.5K | 83,745 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-22 | 2024-08-26 | 5,000 | — | $0 | 75,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-08-22 | 2024-08-26 | 5,000 | — | $0 | 85,880 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-08-19 | 2024-08-21 | 7,973 | $12.01 | $95.8K | 80,880 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 12,083 | — | $0 | 12,084 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 4,027 | — | $0 | 20,140 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 2,418 | — | $0 | 16,932 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-08-17 | 2024-08-21 | 18,528 | — | $0 | 88,853 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-05-22 | 2024-05-24 | 80,000 | — | $0 | 80,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-20 | 2024-05-21 | 12,083 | — | $0 | 24,167 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-20 | 2024-05-21 | 12,084 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-20 | 2024-05-21 | 4,028 | — | $0 | 24,167 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-20 | 2024-05-21 | 2,419 | — | $0 | 19,350 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-05-20 | 2024-05-21 | 13,175 | $11.76 | $154.9K | 70,325 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-05-17 | 2024-05-21 | 30,614 | — | $0 | 83,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-20 | 2024-02-21 | 14,295 | $14.12 | $201.8K | 52,886 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 4,028 | — | $0 | 28,195 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 2,419 | — | $0 | 21,769 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 12,083 | — | $0 | 12,084 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 12,083 | — | $0 | 36,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-02-17 | 2024-02-21 | 30,613 | — | $0 | 67,181 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-02-11 | 2024-02-13 | 48,333 | — | $0 | 48,333 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-11-20 | 2023-11-21 | 7,985 | $8.23 | $65.7K | 36,568 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 12,083 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 2,419 | — | $0 | 24,188 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 4,028 | — | $0 | 32,223 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-11-17 | 2023-11-21 | 18,530 | — | $0 | 44,553 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-08-18 | 2023-08-21 | 8,020 | $10.73 | $86.1K | 26,023 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 2,418 | — | $0 | 26,607 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 4,028 | — | $0 | 36,251 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 12,083 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-08-17 | 2023-08-21 | 18,529 | — | $0 | 34,043 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-05-18 | 2023-05-19 | 2,780 | $10.14 | $28.2K | 13,014 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 4,028 | — | $0 | 40,279 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 2,419 | — | $0 | 29,025 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-05-17 | 2023-05-19 | 6,447 | — | $0 | 15,794 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-05-22 | 4,027 | — | $0 | 44,307 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 2,419 | — | $0 | 31,444 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 4,027 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-02-17 | 2023-02-23 | 6,446 | — | $0 | 6,313 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-02-17 | 2023-02-23 | 3,412 | $7.66 | $26.1K | 9,347 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2023-01-11 | 2023-05-19 | 48,334 | — | $0 | 48,334 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-11-18 | 2022-11-21 | 722 | $5.44 | $3.9K | 5,946 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-11-17 | 2022-11-21 | 2,419 | — | $0 | 33,863 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-11-17 | 2022-11-21 | 2,419 | — | $0 | 6,668 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-08-17 | 2022-08-19 | 2,418 | — | $0 | 36,282 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-08-17 | 2022-08-19 | 2,418 | — | $0 | 2,418 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-08-17 | 2022-08-19 | 725 | $14.96 | $10.8K | 1,693 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 38,700 | — | $0 | 38,700 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 25,800 | — | $0 | 25,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-05-01 | 2021-05-04 | 100,000 | — | $0 | 100,000 | SEC↗ |